Top 50 Health Care VC (Venture Capital) Funds in China in May 2026
Top 50 Health Care VC (Venture Capital) Funds in China in May 2026
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- iMile — iMile is a logistics and courier services provider across the Middle East. It is the first courier company providing smart logistics and courier services to the e-Commerce business and brings the unique value of solving Cash On Delivery (COD). iMile offers a wide range of services like Cash on Delivery with tracking, Real-Time online tracking, 24hours Customer support through Email, Chat, Social Media, SMS, International Transport, Overseas warehouses, and last-mile delivery.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- AnyiPu — AnyiPu is a leading high-tech enterprise in China dedicated to the research, development, production, sales, and full-cycle service of advanced chemical analysis and medical testing instruments. With a strong focus on innovation and quality, the company provides comprehensive solutions that support scientific research, industrial applications,clinical diagnostics, and public health.
- MindOn — MindOn is a robotics company that develops artificial intelligence software and algorithms to create humanoid robots.
- Ubiquitin Bio — Ubiquitin Bio is a research and development manufacturer of in vitro diagnostic products.
We help founders build enduring companies.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
- Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- iOranges Automation — ioranges Automation is an AI & Robotics Company.
- Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
- Aureka Biotechnologies — Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.
Show more...Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Jumeng — Jumeng is a developer of a logistic service platform. The company based in Shanghai, China.
- CreditEase — CreditEase is a business consulting firm that offers wealth management services. It caters areas such as wealth management, credit management, microfinance investment, and microcredit loan origination, and servicing. It operates a peer-to-peer platform that connects lenders with creditworthy borrowers, enabling under-banked students, professionals,and farmers to get loans. The company was founded in 2006 and is based in Beijing, China.CreditEase is a leading FinTech conglomerate in China, specializing in inclusive finance and wealth management, including payment technology, marketplace lending, crowdfunding, robo-advisory, insurance technology, and blockchain products and services. CreditEase actively engages with global FinTech innovators through business incubation, commercial cooperation and investment.
- Cloud Map and Action — CloudMap is an AI technology innovation company dedicated to exploring and breaking through cutting-edge technologies in geographic information and spatial intelligent computing.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more...Investment focus
- Artificial Intelligence, Medical, Biotechnology
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
- Mask Network — Your Portal To The New, Open Internet.
- Oricell Therapeutics — OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- Bloks Technology Group — Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +"as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.
- Noitom Robotics — Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots, as well as the sale of consumer robots and the research and development of intelligent robots.
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
- Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
- Novachip Microelectronics — Novachip Microelectronics is a high-tech enterprise specializing in the design, research and development, and sales of advanced optoelectronic interconnect chips. The company is committed to providing cutting-edge chip products and comprehensive solutions that enable high-speed scale-up and scale-out interconnects in modern data centers.
BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Oukejian — Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.
- Aureka Biotechnologies — Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Angel, Series B
- China, United States
Portfolio highlights
- OncoC4 — OncoC4, we are a clinical-stage biotechnology company committed to transforming cutting-edge science into breakthrough therapies.
- Primelink Bio — Primelink Bio is a Biotechnology firm that is working to to develop next generation of drug delivery systems.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- Dongda Wanshen — Dongda Wanshen specialises in the selling and service of intelligent disinfection technology for hospitals and public health facilities.
- Huamei Haolian — Huamei Haolian specializes in providing telemedicine and medical tourism services.
- Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United Kingdom, United States
Portfolio highlights
- BasePoint Origin — BasePoint Origin is a high-tech company focused on developing an AI operating system that automatically characterizes enterprise business processes. This system replaces traditional manual methods—such as expert visits, data collection, and modeling—with AI, greatly enhancing the efficiency and accuracy of optimizing business processes.
- Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
- Coherent Technology — Coherent Technologies, a company that provides superconducting quantum computing technology solutions and quantum computing services, was founded at the Beijing Academy of Quantum Information Science. Leveraging the academy's foundation in superconducting quantum computing science and engineering research, Coherent Technologies has graduallyconstructed a complete superconducting quantum computing measurement and control solution, as well as the ability to develop complete quantum computers.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Seed
- China, Hong Kong, United States
Portfolio highlights
- Hengpujiguang — Hengpujiguang is a developer of 3D printing metal machine.
- Yinli Electric — Ningxia Yinli Electric Co., Ltd. is mainly engaged in the production and research and development of reactors and transformers. At present, the company's main products include: three-phase filter reactors, four-phase five-column reactors, water-cooled reactors, three-phase AC reactors, hollow core Reactors, isolation transformers andhigh-frequency transformers, etc.
- Depei Open Source — Depei Open Source is an AI and Robotics open source community in China.
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Angel
- China, United States, France
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Zhizai Wujie — Zhizai Wujie is a robotics company that specializes in research, development, and application of humanoid robots.
- Direct Drive Technology — Direct Drive Technology provides direct drive solutions to replace the reduction gears in any machine. The company has a complete set of technologies for robot joints from sensors, drivers to motor bodies. Drive Tech uses a unique direct drive precise & powerful motion solution, thereby helping many other industries to boost different products.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
- Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
- Spiro Medical — Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Spiro Medical — Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.
- Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- HjMicro — Hongjun Microelectronics is committed to the development of "higher efficiency and easier deployment" server processor (CPU) chips based on the ARM architecture, mainly for the data center cloud computing market.
- ZSPepLib — Zonsen PepLib Biotech Inc. Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
- Corerain Technologies — Corerain Technologies provides high performance AI acceleration solutions to embedding frontend, edge and backend AI devices.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Series B
- China, India, Canada
Portfolio highlights
- PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
- BRC Biotechnology — BRC Biotechnology specializes in quality testing services for biopharmaceutical compliance. BRC Biotechnology supports biological agents, quality evaluation of biopharmaceutical goods such as cell gene therapy, nucleic acid medications, and vaccines.
- Fuzhi Internet Technology — Fuzhi Internet is a technology company focused on intelligent manufacturing in the apparel industry. It enhances collaboration across the apparel supply chain through digital solutions for production, management, and supply chain processes. Using a cloud-based platform, Fuzhi Internet enables traditional apparel companies to achieve intelligenttransformation, optimize production, and reduce costs.
Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Hong Kong
Portfolio highlights
- Editact — Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.
- Artec Bio — Artec Bio is an innovative biotechnology company that specializes in the development of next-generation protein degradation drugs, leveraging cutting-edge research and technology to target and eliminate disease-causing proteins.
- Baiyi Pharmaceutical — Baiyi Pharmaceutical is a research-driven pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for neurological diseases, aiming to address unmet medical needs and improve patient outcomes.
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more...Investment focus
- Manufacturing, Health Care, Information Technology
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- MAXVAX — MAXVAX aims to provide novel vaccine development and commercialization.
- Tauren — Tauren is a domestic and hybrid design enterprise of analog and analog-digital chips. At present, the company has won the recognition of the top first-line customers and the strong support of the first-line investment institutions; in the future, it will continue to cultivate the analog and analog-digital hybrid design track, and provide highlycompetitive standardized products for the market landing demand. Provide customers with stable and first-class quality semiconductor products.
- Maxphotonics — Maxphotonics has obtained 448 patents and 23 computer software copyrights. Specifically pulsed fiber lasers, CW fiber lasers, QCW fiber lasers, diode lasers, scientific research fiber lasers, and customized laser solutions, and has achieved independent production of laser core optical components such as pump source, pump combiner, energy combiner,fiber grating, laser output head, isolator, mode stripper, acoustic-optic modulator, and mode matcher.Maxphotonics products can be widely used in marking, engraving, cutting, drilling, cladding, welding, surface treatment, rapid prototyping, additive manufacturing, and other processing technologies. The sales and service network covers Asia, Europe, America, Oceania, etc. countries and regions.
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Angel, Series B
- China, United States, Canada
Portfolio highlights
- Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
- Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Funding Round
- China, United States
Portfolio highlights
- Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
- CytoLynx Therapeutics — CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
- Vivatides Therapeutics — Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Nottada — Nottada is a manufacturer that focuses on the research and development of high-performance fibers and composite materials.
- Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
- Mingche Technology — Mingche Technology is an innovative ophthalmic medical device company.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
- Synaptic Medical — Synaptic Medical is a medical device company focused on the treatment of cardiac arrhythmias and other cardiovascular diseases.
- MicuRx Pharmaceuticals — MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more...Investment focus
- Health Care, Artificial Intelligence, Biotechnology
- Series A, Series B, Funding Round
- China, United States, Hong Kong
Portfolio highlights
- Alluxio — Accelerate AI workloads, increase GPU utilization, and reduce infrastructure costs with Alluxio's AI-optimized, highly-distributed cache.
- Triastek — Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
- Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.
Show more...Investment focus
- Information Technology, Artificial Intelligence, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- AIpark — AIpark is provides a smart parking management solution. AIPark upgrades traditional parking spaces into “smarter ones” for local governments or businesses by leveraging on its in-house visual recognition technologies.
- XYZ Robotics — XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation. The company develops autonomous robotic solutions for put wall sorting and goods-to-person picking. Its robot sorts unorganized, random warehouse goods into groups of customer orders. The solution embodies its strength in deeplearning and robotics.
- Danke Apartment — Danke Apartment (蛋壳公寓) is a leading internet enabled apartment management startup in China. Founded in Jan 2015, Danke is managing over 320K apartment units in Beijing, Shanghai, Shenzhen, Hangzhou, etc
ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.
Show more...Investment focus
- Artificial Intelligence, Software, E-Commerce
- Series A, Seed, Series B
- China, United States, Singapore
Portfolio highlights
- Teable — Teable is an AI-driven, no-code, enterprise-grade database built on PostgreSQL that uses a spreadsheet-like interface to enable rapid creation of complex applications. It supports AI integration, real-time collaboration, and private deployment, offering a fast, scalable, and secure solution for efficient app development without coding.
- ImageDT — ImageDT is a Enterprise services company.
- Zhaogang.com — Zhaogang.com is a website that is specialized in steel trading information services for buyers and suppliers. Zhaogang.com obtained ten millions of dollars in angel funding at the end of 2011. It was launched in 2012.
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more...Investment focus
- Health Care, Biotechnology, Manufacturing
- Series A, Series B, Series C
- China, United States
Portfolio highlights
- BOTSINGTECH — BOTSINGTECH is an enterprise specialized in R&D and manufacturing of trackless guided all position crawling welding robot systems.
- Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
- Huamei Titanium Technology — Huamei Titanium Technology specializes in the research, development, and manufacturing of liquid crystal phased array antennas.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more...Investment focus
- Manufacturing, Artificial Intelligence, Software
- Series A, Series B, Seed
- China, Hong Kong, United States
Portfolio highlights
- Infinigence — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
- SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
- Lanyue Intelligent — Lanyue Intelligent specializes in AI cloud browser technology that enhances productivity and reduces computing costs for cloud-based autonomous agents.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Manufacturing, Medical, Health Care
- Series A, Seed, Series B
- China, United States, India
Portfolio highlights
- Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
- Deruicore — Deruicore is an integrated research and development based manufacturing company.
- Sunseeker — Sunseeker Power Equipment specializes in the manufacturing and supplying of garden tools, focusing on innovation in the realm of outdoor power equipment. The product range includes robotic lawn mowers, cordless Li-ion battery-powered tools, and petrol-powered equipment, catering to both garden and agricultural needs. The brand emphasizes onproviding solutions that enhance efficiency and ease of use in maintaining outdoor spaces. Sunseeker Power Equipment's offerings are designed to meet the demands of a global market, with a significant emphasis on exporting their products under the brand name 'SUNSEEKER 山科'. The company's portfolio extends to engines and a variety of garden tools series, showcasing a commitment to diversifying and expanding its product lineup to address the evolving needs of its customers.
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Canada
Portfolio highlights
- CytoNiche — CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
- Metanovas Biotech — Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
- Artivila Therapeutics — Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- AOSSCI — AOSSCI is an smart unmanned aircraft system developer Based in China.
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China.
Show more...Investment focus
- E-Commerce, Manufacturing, Software
- Series A, Angel, Seed
- China, United States, Hong Kong
Portfolio highlights
- Shala Shike — Shala Shike is a supply chain technology company that focuses on catering, dining, salad carving service, cold chain distribution, and smart machine unmanned sales services.
- HooRii Technology — HooRii Technology is a provider of commercial distribution software systems spawned by the structural Internet of Things concept. It specializes ini end-to-end, edge-to-edge, software, hardware, and other Thread solutions.
- Ruisi Zhilian Technology — Beijing Ruisi Zhilian Technology Co., Ltd. is an innovative technology company specializing in AI computing power management and scheduling. it is committed to building an industry-leading data center-grade AI computing power management platform and solutions.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more...Investment focus
- Manufacturing, Semiconductor, Electronics
- Series A, Series B, Funding Round
- China, Hong Kong, Singapore
Portfolio highlights
- Letuo Technology — Letuo Technology is a ASIC chip design & manufacturing firm focused on architecture and back end design, RTL coding, DFT, and synthesis.
- Heguang New Energy — Heguang New Energy is China's largest producer of square silicon cores for polysilicon and has long-term and stable purchase agreements with a number of major polysilicon producers.
- Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.
Show more...Investment focus
- Software, Artificial Intelligence, Internet
- Series A, Seed, Series B
- China, United States, Singapore
Portfolio highlights
- BasePoint Origin — BasePoint Origin is a high-tech company focused on developing an AI operating system that automatically characterizes enterprise business processes. This system replaces traditional manual methods—such as expert visits, data collection, and modeling—with AI, greatly enhancing the efficiency and accuracy of optimizing business processes.
- Lanzhou Technology — Lanzhou Technology is a cognitive intelligence company that provides business insights products.
- Zongwei Automation — Shanghai Zongwei Automation Co., Ltd. (ZONGWEI) is a research and development enterprise focusing on automation flexibility technology and solutions. The company has leading linear motion control core technology and experience, and independently developed key supporting equipment such as controllers, driver series and feedback systems dedicated tolinear motion. High-performance products and super-optimal solutions have been widely used in semiconductors, new energy, high-end daily chemicals, 3C electronics and other fields, improving delivery efficiency and reducing production costs for many world-class industrial giants and listed company customers.
LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- China, United States, France
Portfolio highlights
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
- Starna Therapeutics — Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
- ALLYRNA Pharmaceuticals — ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers.
Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, India
Portfolio highlights
- Hurrichip — Hurrichip manufactures gallium nitride semiconductor lasers that is used during semiconductor testing.
- Ronghe Medical — Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications.
- Jinghe Semiconductor — Jinghe Semiconductor is a high-tech enterprise specializing in the research, development, and manufacturing of advanced equipment for semiconductor devices, providing cutting-edge solutions that support the production of integrated circuits, microchips, and other core components essential to the global electronics industry.
Tiantu Capital is a venture capital association.
Show more...Investment focus
- Food and Beverage, E-Commerce, Medical
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- RIGHTWAY — Ruiwei New Materials is a developer of biodegradable materials focused on applying them to the consumer market. It provides end-brand customers with integrated solutions from laboratory research and development to material processing and manufacturing.
- Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
- Signet Therapeutics — Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.
Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.
Show more...Investment focus
- Software, Biotechnology, Manufacturing
- Series A, Series B, Angel
- China, United States, Canada
Portfolio highlights
- APOLLOMICS — APOLLOMICS is a biotechnology company that develops domestic clinical testing reagents and provides disease testing services.
- Zhiyou Wujie — Zhiyou Wujie will develop specialized robots for ship painting, cleaning, and container interior space planning, based on a general-purpose large model.
- Signet Therapeutics — Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.
Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.
Show more...Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Seed, Series B
- China, United States, France
Portfolio highlights
- Lingke Medical — Lingke Medical is a company specializing in intelligent temperature-controlled therapy technology, dedicated to developing innovative medical solutions that integrate advanced sensing, precise thermal regulation, and smart control systems to improve treatment effectiveness, patient comfort, and clinical outcomes across a range of healthcareapplications.
- Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
- Lingji Tianci Technology — Lingji Tianci is an innovative technology company specializing in AI companionship solutions for children, focusing on “AI family interactive social” products and smart hardware. The company aims to become the “Nintendo” of the children’s AI development partner sector, leveraging intelligent hardware and proprietary AI content to create interactiveexperiences that encourage exploration and growth for families and children.
Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund(SHENZHEN)LLP with a size of 6 Billion Yuan.Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhenventure capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%).
Show more...Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Seed
- China
Portfolio highlights
- Huanova — Huanova develops a series of hemostatic materials and filling consumables that can be used in the fields of surgery. It was founded in 2017 by Dr. Wang Huanan, who has a double doctorate degree in engineering and medicine, a young expert in the National "Thousand Talents Program", and a young Rubicon scholar in the Netherlands.
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Linkerbot — Lingxin Qiaoshou focuses on the research and development and production of embodied intelligent platforms with "dexterous hands + cloud-based intelligent brain" as the core.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series C, Series B
- China, United States, India
Portfolio highlights
- QureBio — QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug developmentincluding phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform.The company was founded in 2017 and is based in Pudong District, Shanghai.
- Pleryon Therapeutics — Innovations in biofunctional polymers
- Tingsheng Technology — TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digitalheart model.
BIOCHING CAPITAL is an investment management firm.
Show more...Investment focus
- Medical Device, Medical, Biotechnology
- Angel, Series A, Seed
- China
Portfolio highlights
- Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
- Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
- Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more...Investment focus
- Manufacturing, Software, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- BuChou Quantum — BuChou Quantum’s vision is to create quantum computers with real, practical application value by pursuing deep “software–hardware synergy,” meaning they design quantum hardware and quantum software in tandem so each enhances the other, enabling more powerful, efficient, and usable quantum computing systems.
- Soundbridge AI — Soundbridge AI specializes in developing cutting-edge, AI-powered speech rehabilitation solutions designed to assist individuals with speech impairments in improving communication skills through personalized, adaptive therapy.
- Spirit AI — Spirit AI develops 'Universal Brains' for robotics, specializing in general-purpose embodied models that bridge the gap between simulation and real-world deployment. These models provide robots with robust generalization and precise physical interaction capabilities across diverse environments. Technical efficacy is validated by theSpirit Series (notably Spirit v1.5), which currently leads the RoboChallenge global benchmarks. Through rigorous R&D, Spirit AI aims to integrate versatile robotic companions into the modern workforce, advancing the era of embodied AI.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!